MOLECULIN BIOTECH INC (MBRX) Stock Cash Flow
NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -23.23M | -21.76M | -29.77M | -29.02M | -15.89M | |||
| Depreciation Amortization | 125.00K | 126.00K | 127.00K | 130.00K | 164.00K | |||
| Change In Working Capital | 1.86M | 231.00K | 1.62M | 224.00K | 1.04M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 15.00K | |||
| Other non cash items | -467.00K | -2.46M | 3.92M | 1.03M | -4.26M | |||
| OPERATING CASH FLOW | -21.71M | -23.86M | -24.10M | -27.64M | -18.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -13.00K | -124.00K | -67.00K | -19.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | -13.00K | -124.00K | -67.00K | -19.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 12.66M | 4.66M | 4.17M | 0.00 | 74.75M | |||
| Other Financing Activity | N/A | -26.00K | 485.00K | -23.00K | -23.00K | |||
| FINANCING CASH FLOW | 12.63M | 4.63M | 4.65M | -23.00K | 74.72M | |||
| Exchange Rate Effect | -20.00K | -32.00K | -21.00K | -29.00K | -24.00K | |||
| CHANGE IN CASH | -9.11M | -19.27M | -19.59M | -27.76M | 55.73M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.71M | -23.86M | -24.10M | -27.64M | -18.95M | |||
| Capital Expenditure | N/A | -13.00K | -124.00K | -67.00K | -19.00K | |||
| FREE CASH FLOW | -21.72M | -23.88M | -24.23M | -27.71M | -18.97M | |||
All data in USD